TRial on the Endocrine Activity of Neoadjuvant Degarelix

NCT02005887 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer Invasive Nos

Interventions

DRUG: triptorelin
DRUG: degarelix
DRUG: letrozole

Sponsor

ETOP IBCSG Partners Foundation